Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm
Inari Medical, Inc. (NARI)
Company Research
Source: Business Wire
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) on behalf of the company’s shareholders.Since January 2024, shares of Inari’s common stock have declined in value from a trading price of over $65.00 per share to a current trading price of below $47.00 per share, a decline of over $18.00 per share, or approximately 28% in value.The investigation seeks to determine whether Inari and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders.Inari shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):https://kaskelalaw.com/cas
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the FirmGlobeNewswire
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $50.00 price target on the stock.MarketBeat
- Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]Yahoo! Finance
- Inari Medical, Inc. (NASDAQ: NARI) was upgraded by analysts at Leerink Partnrs to a "hold" rating.MarketBeat
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $47.00 price target on the stock.MarketBeat
NARI
Earnings
- 7/30/24 - Miss
NARI
Sec Filings
- 9/18/24 - Form 4
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- NARI's page on the SEC website